Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11056374rdf:typepubmed:Citationlld:pubmed
pubmed-article:11056374lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:11056374lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:11056374lifeskim:mentionsumls-concept:C0121300lld:lifeskim
pubmed-article:11056374lifeskim:mentionsumls-concept:C0182638lld:lifeskim
pubmed-article:11056374lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:11056374lifeskim:mentionsumls-concept:C0034606lld:lifeskim
pubmed-article:11056374lifeskim:mentionsumls-concept:C0136946lld:lifeskim
pubmed-article:11056374pubmed:issue6lld:pubmed
pubmed-article:11056374pubmed:dateCreated2000-12-15lld:pubmed
pubmed-article:11056374pubmed:abstractTextA quick and reproducible method for radiolabeling of Photosan-3(R), a photosensitizer used worldwide for photodynamic therapy (PDT) of cancer, with radioisotope of technetium ((99m)Tc) was developed. The radiotracer was evaluated for radiochemical purity, stability, and finally tissue distribution in a murine tumor model. The (99m)Tc-Photosan-3 prepared by using (99m)Tc-pertechnetate in place of reduced (99m)Tc demonstrated better labeling efficiency (>90%) and reproducibility. The procedure also minimized the radiation exposure to the radiochemist as handling time was considerably reduced. Due to the commercial availability of Photosan-3, the risk of batch-to-batch variation in the in situ synthesis of hematoporphyrin derivative, which is a complex mixture of at least five compounds, was also significantly reduced. The biodistribution studies and tumor scintigraphy confirmed that (99m)Tc-labeled Photosan-3 was preferentially taken up by the neoplastic tissue in a manner similar to the parent compound. In addition to applications in tumor imaging, (99m)Tc-Photosan-3 could also be used for estimating tumor uptake of Photosan-3 as may be required for individualization of clinical protocols of PDT.lld:pubmed
pubmed-article:11056374pubmed:languageenglld:pubmed
pubmed-article:11056374pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11056374pubmed:citationSubsetIMlld:pubmed
pubmed-article:11056374pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11056374pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11056374pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11056374pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11056374pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11056374pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11056374pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11056374pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11056374pubmed:statusMEDLINElld:pubmed
pubmed-article:11056374pubmed:monthAuglld:pubmed
pubmed-article:11056374pubmed:issn0969-8051lld:pubmed
pubmed-article:11056374pubmed:authorpubmed-author:SharmaR KRKlld:pubmed
pubmed-article:11056374pubmed:authorpubmed-author:ChauhanU PUPlld:pubmed
pubmed-article:11056374pubmed:authorpubmed-author:SinghA KAKlld:pubmed
pubmed-article:11056374pubmed:authorpubmed-author:GoelH CHClld:pubmed
pubmed-article:11056374pubmed:authorpubmed-author:BabbarA KAKlld:pubmed
pubmed-article:11056374pubmed:issnTypePrintlld:pubmed
pubmed-article:11056374pubmed:volume27lld:pubmed
pubmed-article:11056374pubmed:ownerNLMlld:pubmed
pubmed-article:11056374pubmed:authorsCompleteYlld:pubmed
pubmed-article:11056374pubmed:pagination587-92lld:pubmed
pubmed-article:11056374pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:11056374pubmed:meshHeadingpubmed-meshheading:11056374...lld:pubmed
pubmed-article:11056374pubmed:meshHeadingpubmed-meshheading:11056374...lld:pubmed
pubmed-article:11056374pubmed:meshHeadingpubmed-meshheading:11056374...lld:pubmed
pubmed-article:11056374pubmed:meshHeadingpubmed-meshheading:11056374...lld:pubmed
pubmed-article:11056374pubmed:meshHeadingpubmed-meshheading:11056374...lld:pubmed
pubmed-article:11056374pubmed:meshHeadingpubmed-meshheading:11056374...lld:pubmed
pubmed-article:11056374pubmed:meshHeadingpubmed-meshheading:11056374...lld:pubmed
pubmed-article:11056374pubmed:meshHeadingpubmed-meshheading:11056374...lld:pubmed
pubmed-article:11056374pubmed:meshHeadingpubmed-meshheading:11056374...lld:pubmed
pubmed-article:11056374pubmed:meshHeadingpubmed-meshheading:11056374...lld:pubmed
pubmed-article:11056374pubmed:meshHeadingpubmed-meshheading:11056374...lld:pubmed
pubmed-article:11056374pubmed:meshHeadingpubmed-meshheading:11056374...lld:pubmed
pubmed-article:11056374pubmed:meshHeadingpubmed-meshheading:11056374...lld:pubmed
pubmed-article:11056374pubmed:meshHeadingpubmed-meshheading:11056374...lld:pubmed
pubmed-article:11056374pubmed:meshHeadingpubmed-meshheading:11056374...lld:pubmed
pubmed-article:11056374pubmed:meshHeadingpubmed-meshheading:11056374...lld:pubmed
pubmed-article:11056374pubmed:meshHeadingpubmed-meshheading:11056374...lld:pubmed
pubmed-article:11056374pubmed:meshHeadingpubmed-meshheading:11056374...lld:pubmed
pubmed-article:11056374pubmed:year2000lld:pubmed
pubmed-article:11056374pubmed:articleTitleEvaluation of (99m)Tc-labeled photosan-3, a hematoporphyrin derivative, as a potential radiopharmaceutical for tumor scintigraphy.lld:pubmed
pubmed-article:11056374pubmed:affiliationDepartment of Radiopharmaceuticals, Institute of Nuclear Medicine and Allied Sciences, Lucknow Marg, Delhi, India.lld:pubmed
pubmed-article:11056374pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11056374pubmed:publicationTypeEvaluation Studieslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11056374lld:pubmed